Increased Concentration of Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) Predate Onset of Rheumatoid Arthritis

被引：0
|
作者：
Johansson, Linda [1 ]
Arlestig, Lisbeth [1 ]
Kokkonen, Heidi [1 ]
Rantapaa-Dahlqvist, Solbritt [2 ]
机构：
[1] Umea Univ, Publ Hlth & Clin Med Rheumatol, Umea, Sweden
[2] Umea Univ, Dept Publ Hlth & Clin Med Rheumatol, Umea, Sweden
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
926
引用
收藏
页数：1
相关论文
共 50 条
  • [21] RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA-B LIGAND (RANKL) AND OSTEOPROTEGERIN (OPG) IN RADICULAR CYSTS, DENTIGEROUS CYSTS AND HEALTHY VOLUNTEERS
    Pechalova, Petia F.
    Poriazova, Elena G.
    Pavlov, Nikolai V.
    Gospodinov, Dimitar L.
    COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES, 2016, 69 (03): : 385 - 392
  • [22] Inhibition of receptor activator of nuclear factor kappa-B ligand pathway for the management of aggressive osteosarcoma
    Panagiotidis, Ioannis
    Christoulas, Dimitrios
    Terpos, Evangelos
    ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (24)
  • [23] Receptor Activator of Nuclear Factor kappa-B Ligand is Not Regulated During Chronic Osteomyelitis in Pigs
    Luthje, F. L.
    Skovgaard, K.
    Jensen, H. E.
    Blirup-Plum, S. A.
    Henriksen, N. L.
    Aalbaek, B.
    Jensen, L. K.
    JOURNAL OF COMPARATIVE PATHOLOGY, 2020, 179 : 7 - 24
  • [24] RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA-B LIGAND EXPRESSION PREDICTS OVARIAN CANCER OUTCOME
    Koegl, J.
    Wieser, V.
    Sprung, S.
    Fiegl, H.
    Marth, C.
    Zeimet, A. G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A482 - A483
  • [25] Differential expression of receptor activator of nuclear factor kappa B (RANK) and its ligand (RANKL) in rheumatoid arthritis synovial tissue and peripheral blood cells
    Krystufkova, O.
    Sinkora, J.
    Niederlova, J.
    Rehakova, Z.
    Jarosova, K.
    Ruzickova, S.
    Vencovsky, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 132 - 133
  • [26] Cementocytes Express Receptor Activator of the Nuclear Factor Kappa-B Ligand in Response to Endodontic Infection in Mice
    De Rossi, Andiara
    Fukada, Sandra Yasuyo
    De Rossi, Moara
    Bezerra da Silva, Raquel Assed
    Queiroz, Alexandra Mussolino
    Nelson-Filho, Paulo
    Bezerra da Silva, Lea Assed
    JOURNAL OF ENDODONTICS, 2016, 42 (08) : 1251 - 1257
  • [27] STUDY OF SERUM OSTEOPROTEGERIN AND RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA-B LIGAND IN PATIENTS WITH RHEUMATIC DISEASES
    Geneva-Popova, Mariela
    Popova, Stanislava
    JOURNAL OF IMAB, 2021, 27 (04): : 4170 - 4177
  • [28] Fracture risks and their mechanisms in atopic dermatitis, focusing on receptor activator of nuclear factor kappa-B ligand
    Sakai, Takashi
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2023, 48 (11) : 1209 - 1213
  • [29] Osteoprotective Effect of Cimiracemate in Glucocorticoid-Induced Osteoporosis by Osteoprotegerin/Receptor Activator of Nuclear Factor κB/Receptor Activator of Nuclear Factor Kappa-B Ligand Signaling
    Ding, Zheng
    Shi, Huifeng
    Yang, Wei
    PHARMACOLOGY, 2019, 103 (3-4) : 163 - 172
  • [30] Assessment of receptor activator of nuclear factor kappa B ligand (RANKL) and osteoprotegerin (OPG) in lymphoma patients
    Ayoub, M.
    Gadallah, H.
    Hegab, H.
    Khattab, D.
    Mostafa, N.
    EJC SUPPLEMENTS, 2010, 8 (04): : 22 - 22
12345